Provided by Tiger Fintech (Singapore) Pte. Ltd.

CareDx

16.88
-1.2500-6.89%
Post-market: 16.25-0.6300-3.73%19:45 EDT
Volume:2.02M
Turnover:34.53M
Market Cap:935.59M
PE:18.15
High:17.99
Open:17.67
Low:16.83
Close:18.13
Loading ...

CareDx Reports Strong 2024 Financial Results and Growth

TIPRANKS
·
27 Feb

BRIEF-CareDx Q4 Adjusted EPS USD 0.18 Vs. IBES Estimate USD 0.13

Reuters
·
27 Feb

CareDx Inc Outlook FY Revenue to Be in Range of $365 Mln to $375 Mln

THOMSON REUTERS
·
27 Feb

CareDx Inc Outlook FY Adjusted Ebitda Gain to Be in Range of $29 Mln to $33 Mln

THOMSON REUTERS
·
27 Feb

CareDx Inc FY2025 REV View $369.5 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
27 Feb

CareDx Q4 Net Income USD 87.7 Million

THOMSON REUTERS
·
27 Feb

CareDx reports District Court reverses jury decision in patent infringement case

TIPRANKS
·
25 Feb

BUZZ-Natera falls as $96 mln patent verdict overturned

Reuters
·
25 Feb

CareDx Inc - District Court Reverses Jury Decision in Patent Infringement Case Overturning Prior $96 Mln Verdict

THOMSON REUTERS
·
25 Feb

CareDx Inc - IF Plaintiff Appeals, CareDx Will Continue to Vigorously Defend Technology

THOMSON REUTERS
·
25 Feb

CareDx Inc - All Patent Claims Asserted Against CareDx Are Found to Be Invalid

THOMSON REUTERS
·
25 Feb

CareDx Announces District Court Reverses Jury Decision in Patent Infringement Case Overturning Prior $96 Million Verdict

Business Wire
·
25 Feb

CareDx gets $96 million jury win for Natera overturned

Reuters
·
25 Feb

CareDx Announces Study Showing Alloseq Cfdna Highly Accurate in Detecting Rejection in Organ Transplant Patients

THOMSON REUTERS
·
20 Feb

CareDx Announces Study Showing AlloSeq cfDNA Highly Accurate in Detecting Rejection in Organ Transplant Patients

Business Wire
·
20 Feb

Catherine Wood Reduces Stake in CareDx Inc: A Strategic Portfolio Adjustment

GuruFocus
·
15 Feb

Exploring Three High Growth Tech Stocks In The United States

Simply Wall St.
·
15 Feb

CareDx Announces Presentation of Data at 2025 Tandem Meetings Demonstrating Strong Performance of AlloHeme in Early Relapse Detection for Hematologic Malignancies

Business Wire
·
13 Feb

Investing in CareDx (NASDAQ:CDNA) a year ago would have delivered you a 187% gain

Simply Wall St.
·
12 Feb

Press Release: CareDx to Report Fourth Quarter and Full Year 2024 Financial Results

Dow Jones
·
11 Feb